Development of treatment and clinical results in childhood acute myeloid leukemia in the Czech Republic

被引：3

作者：

Sramkova L. ^{[1
]}

Sterba J. ^{[2
]}

Hrstkova H. ^{[3
]}

Mihal V. ^{[4
]}

Blazek B. ^{[5
]}

Timr P. ^{[6
]}

Cerna Z. ^{[7
]}

Prochazkova D. ^{[8
]}

Hak J. ^{[9
]}

Sedlacek P. ^{[1
]}

Janotova I. ^{[1
]}

Vodickova E. ^{[10
]}

Zemanova Z. ^{[11
]}

Jarosova M. ^{[12
]}

Oltova A. ^{[13
]}

Zdrahalova K. ^{[1
]}

Hrusak O. ^{[1
]}

Mejstrikova E. ^{[1
]}

Schwarz J. ^{[14
]}

Zuna J. ^{[1
]}

Trka J. ^{[1
]}

Stary J. ^{[1
]}

机构：

[1] Department of Pediatric Hematology and Oncology, 2nd Medical School, Charles University Prague, Prague

[2] Department of Pediatric Oncology, University Hospital Brno, Brno

[3] Pediatric Department, University Hospital Brno, Brno

[4] Pediatric Department, University Hospital Olomouc, Olomouc

[5] Pediatric Department, University Hospital, Ostrava-Poruba

[6] Pediatric Department, Hospital Ceske Budejovice, Ceske Budejovice

[7] Pediatric Department, University Hospital, Plzen

[8] Pediatric Department, Masaryk's Hospital, Usti nad Labem

[9] Pediatric Department, University Hospital, Hradec Kralove

[10] Department of Clinical Hematology, University Hospital, Prague

[11] Center of Tumor Cytogenetics, 1st Medical School, Charles University Prague, Prague

[12] Department of Hematooncology, University Hospital Olomouc, Olomouc

[13] Department of Medical Genetics, University Hospital Brno, Brno

[14] Institute of Hematology and Blood Transfusion, Prague

来源：

memo - Magazine of European Medical Oncology | 2013年 / 6卷 / 1期

关键词：

Acute myeloid leukemia; AML-BFM; 2004; 93; 98; Children; Czech Republic;

D O I：

10.1007/s12254-012-0059-3

中图分类号：

学科分类号：

摘要：

Purpose: Treatment of childhood acute myeloid leukemia (AML) was unified in the year 1993 according to acute myeloid leukemia-Berlin-Frankfurt-Munster (AML-BFM) protocols in the Czech Republic. We evaluated data on clinical and therapeutic results in children with AML treated in three subsequent trials, comparing two periods, June 1993 to February 2004 (AML-BFM 93 and 98) vs. March 2004 to December 2009 (AML-BFM 2004 trial). Patients and methods: Data of 182 eligible patients were analyzed, 125 in AML-BFM 93 and 98 trials, and 57 in AML-BFM 2004 trial enrolled prior to December 2009. Down syndrome patients were excluded from analysis. Results: In studies AML-BFM 93 and 98, 79.2 % of 125 patients achieved complete remission (CR), 19 patients (15.2 %) suffered from early death, 7 (5.6 %) were nonresponders, 33 (33.3 %) relapsed, 12 (12.1 %) died in CR, and 2 patients (2.0 %) developed secondary malignancy. The estimated probability of event-free survival (pEFS) at 5 years was 41.6 %, the overall survival (OS) at 5 years was 46.4 %. In AML-BFM 2004 trial, 93 % of 57 patients attained CR, 3 patients (5.2 %) suffered from early death, 1 (1.8 %) was nonresponder, 16 (30.2 %) relapsed, 2 (3.8 %) died in CR, and 2 patients (3.5 %) developed secondary malignancy. The estimated pEFS at 5 years was 56.1 %, 5-years overall survival (5y-OS) was 73.7 %. Conclusion: Gradual improvement of CR rate and OS together with decreasing incidence of toxic deaths in AML patients were achieved because of gain of experience with very intensive modern treatment centralized in a limited number of institutions. © 2012 Springer-Verlag Wien.

引用

页码：41 / 45

页数：4

共 50 条

[1] Development of treatment and clinical results in childhood acute myeloid leukemia in the Slovak Republic
Kolenova A.
Bubanska E.
Oravkinova I.
Subova Z.
Mikeskova M.
Hederova S.
Petrzalkova D.
Striezencova Z.L.
Fabri O.
Copakova L.
Chocholova A.
Sufliarska S.
Horakova J.
Cap J.
Foltinova A.
Sejnova D.
Kaiserova E.
memo - Magazine of European Medical Oncology, 2013, 6 (1) : 46 - 53
[2] Development of treatment and clinical results in childhood acute myeloid leukemia in Poland
Balwierz W.
Pawinska-Wasikowska K.
Klekawka T.
Czogala M.
Matysiak M.
Fic-Sikorska B.
Adamkiewicz-Drozynska E.
MacIejka-Kapuscinska L.
Chybicka A.
Potocka K.
Wachowiak J.
Skalska-Sadowska J.
Kowalczyk J.
Wojcik B.
Wysocki M.
Koltan S.
Krawczuk-Rybak M.
Muszynska-Roslan K.
Mlynarski W.
Stolarska M.
Urasinski T.
Kamienska E.
Szczepanski T.
Tomaszewska R.
Sobol G.
Mizia-Malarz A.
Karolczyk G.
Podhorecka J.
Wieczorek M.
Karpinska-Derda I.
Badowska W.
Moryl-Bujakowska A.
memo - Magazine of European Medical Oncology, 2013, 6 (1) : 54 - 62
[3] Development of treatment and clinical results in childhood acute myeloid leukemia in Slovenia in the period from 1991 to 2010
Orjana Velikonja
Milica Stefanović
Lidija Kitanovski
Helena Podgornik
Janez Jazbec
memo - Magazine of European Medical Oncology, 2014, 7 (1) : 56 - 62
[4] Treatment results of childhood acute myeloid leukemia in Serbia
Nada K.
Milos K.
Dragana V.
Lidija D.
Dragan M.
Bojana S.
Dejan S.
Jelena L.
Ankica J.
Milena J.
Nada K.
Gordana K.
Predrag R.
Dragana J.
memo - Magazine of European Medical Oncology, 2013, 6 (1) : 63 - 68
[5] Development of treatment and clinical results in childhood acute myeloid leukemia in Slovenia in the period from 1991 to 2010
Velikonja, Orjana
Stefanovic, Milica
Kitanovski, Lidija
Podgornik, Helena
Jazbec, Janez
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2014, 7 (01) : 56 - 62
[6] Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic
Stary, J.
Jabali, Y.
Trka, J.
Hrusak, O.
Gajdos, P.
Hrstkova, H.
Sterba, J.
Blazek, B.
Hak, J.
Prochazkova, D.
Cerna, Z.
Smisek, P.
Sedlacek, P.
Vavra, V.
Mihal, V.
Hrodek, O.
LEUKEMIA, 2010, 24 (02) : 425 - 428
[7] Treatment of childhood acute myeloid leukemia
ter Bals, Edske
Kaspers, Gertjan J. L.
EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (05) : 917 - 929
[8] Development of treatment and clinical results in childhood acute myeloid leukemias in Hungary
Szegedi I.
Jakab Z.
Masát P.
Kiss C.
memo - Magazine of European Medical Oncology, 2013, 6 (1) : 69 - 72
[9] Treatment Outcome in Older Patients With Childhood Acute Myeloid Leukemia
Rubnitz, Jeffrey E.
Pounds, Stanley
Cao, Xueyuan
Jenkins, Laura
Dahl, Gary
Bowman, W. Paul
Taub, Jeffrey W.
Pui, Ching-Hon
Ribeiro, Raul C.
Campana, Dario
Inaba, Hiroto
CANCER, 2012, 118 (24) : 6253 - 6259
[10] Development of secondary skull sarcoma after treatment for childhood acute myeloid leukemia
Ohno, Makoto
Narita, Yoshitaka
Miyakita, Yasuji
Okita, Yoshiko
Kayama, Takamasa
Shibui, Soichiro
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (04) : E49 - E52

← 1 2 3 4 5 →